The global controlled release drug delivery market size projected to register around USD 91.2 billion by 2026, this market is anticipated to grow with 14.3% CAGR during the forecast time period. The market is driven by increasing technology spending in healthcare sector.
Soaring demand for pediatric and geriatric controlled release delivery methods and substitute therapies and increasing consciousness about advantages of these systems over conventional forms are providing a fillip to the controlled release drug delivery market market.
These technologies deliver numerous advantages over old-style delivery forms. Uniform drug effect, reduced dosage and less gastrointestinal side effects, dosage frequency, enhanced patient compliance, improved drug efficacy & safety, and reduced fluctuation of plasma drug levels are some of the advantages delivered by these technologies.
Controlled release drug delivery systems permit reduction in quantity of dose and dose frequency, increased patient compliance and acceptance, less fluctuation in plasma drug levels, uniform drug result, and improved effectualness quantitative relation of administered therapeutic. as compared to traditional delivery, these systems accomplish a chronic therapeutic result, increase foregone conclusion in drug unleash dynamics, and produce concerning delivery at a pre-determined rate regionally or consistently. Thus, with many more blessings offered by these systems, their adoption is slated to extend at a motivating rate over the approaching years.
Market By Release Mechanism
Market By Technology
Market By Application
Market By Geography
North America captures the largest revenue share at 35.6% and will continue to retain its dominance position over the forthcoming years. Speedy acceptance of advanced devices and technologies and high per capita healthcare expenditure are expected to surge the need for connected drug delivery systems in the region. High price of controlled release drug delivery is expected to be the one of the substantial factor in hampering the market growth in emerging regions such as MEA, APAC and Latin America. Though, with the growing numeral of market entrants the device prices are anticipated to fall over time; this will backing the market growth in emerging such countries such as India and China.
The major players associated with the controlled release drug delivery market Capsugel, Orbis Biosciences, Inc., Pfizer, Inc, Merck and Co., Inc., Johnson and Johnson, Alkermes plc, Coating Place, Inc., Depomed, Inc., Corium International, Inc., and Aradigm Corporation. Most of these firms put stress on new product launch and mergers & acquisitions, technological expansion, and strategic partnership activities as part of their commercial growth strategies.
The global medical nonwoven disposables market is forecasted to grow at a CAGR of 6.6% over the forecast time frame and reach around US$ 26.1 billion by 2026. The report provides analysis of global medical non-woven disposables market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year. Market Insights Nonwovens are a unique category of textile product enginee
According to Acumen Research and Consulting, the global plastic surgery instruments market size is anticipated to reach around US$ 1.7 billion by 2026 and expected to grow at a CAGR of 8.5% from period 2019 to 2026. Plastic surgery involves the restoration, replacement, alteration and rehabilitation of body regions, such as the head, skin, musculoskeletal, breast and others. The two main kinds of plastic surgery are cosmetic and reconstructive. Cosmetic o
According to Acumen Research and Consulting, the global upper limb prosthetics market size is expected to worth US$ 1.9 billion by 2026 and poised to grow at a CAGR around 10.5 % from period 2019 to 2026. The prothetics of the upper limbs have gone a long way from their ancient origins to advanced and advanced protheses of today's moments. Today, the highest prothesis implants consist of aluminum, plastics and sophisticated composite components. The
According to Acumen Research and Consulting, the global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. The report provides analysis of global MRI-guided Neurosurgical Ablation market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year. Market Insights An gr
Introduction According to Acumen Research and Consulting, The global self-monitoring blood glucose devices market size is expected to reach US$ 19 billion by 2026 and market is growing at a CAGR of 5 % from 2019 to 2026. Diabetes is a clinical disorder in which the blood glucose level rises owing to the pancreas ' incapacity to generate insulin. Monitoring glucose is one of the most important measures in the leadership of diabetes
Introduction According to Acumen Research and Consulting, the global ovarian cancer diagnostics market is forecasted to grow at striking CAGR around 5.9 % over the forecast time frame and reach around US$ 1.8 billion by 2026. One of the most prevalent kinds of cancer in females is ovarian cancer. It is a cancer which begins in the ovaries. Ovary is a woman reproductive organ that contains eggs or ova. There are two ovaries i